Researchers sought to examine the effectiveness of intradiscal biologics for treating discogenic low back pain and found low-quality evidence supporting it, according to a study published in the February 2022 edition of The Spine Journal.
Biologics
Regenerative medicine in orthopedic surgery has remained an area of interest among Becker's readers in 2021.
Brian Domby, MD, of Florida Medical Clinic in Brandon, started using the MACI regenerative procedure for cartilage repair, the practice said Dec. 21.
Los Angeles-based FullRange Spine & Ortho began offering regenerative treatments using a patient's own stem cells.
New Orleans Pelicans player Zion Williamson has received a biologic injection to promote bone healing in a fracture in his right foot, according to the NBA.
Advertisement
Two medtech companies have partnered to develop 3D-printed regenerative joint implants.
The FDA's clinical hold on Ortho RIT's Ortho-R drug has been lifted, according to a Dec. 13 news release.
Sioux Falls, S.D.-based Sanford Health launched a clinical trial examining the effectiveness of treating osteoarthritis with stem cells across five joints, Sioux Falls Business reported Dec. 8.
The California Institute for Regenerative Medicine has awarded a $5.5 million grant to a University of California Irvine professor to study the use of stem cells to treat chronic cervical spinal cord injury.
Over the past five years, the U.S. has seen a significant spike in the number of clinics advertising stem cell treatments, which claim to treat a range of orthopedic, neurological and autoimmune conditions, among others.